MDFA is committing to macular disease research
On the cover of our latest newsletter, you’ll read how we made your voice heard in Canberra.
Kathy brings to MDFA extraordinary experience as a dynamic and respected senior leader and CEO in the for-purpose sector.
MDFA and the eye health community is saddened to learn of the passing of Mr. Richard Grills
The 2022 Supporter Survey results are in.
Specsavers and Macular Disease Foundation Australia have begun a strategic scoping partnership.
Researchers confirm the AREDS2 formulation is safe for use over a decade.
Faricimab has taken one step closer towards clinics in Australia.
MDFA strives to address challenges for people receiving intravitreal injections.